Fragmin (dalteparin sodium) / Pfizer, Eisai |
2015-001707-31: Survival and quality of life of cancer patients diagnosed with previously unsuspected pulmonary embolism |
|
|
| Ongoing | 4 | 390 | Europe | Dalteparin, Solution for injection in pre-filled syringe, Fragmin® 5000 IU | Hull & East Yorkshire Hospitals NHS Trust, internal academic funds | Incidental Pulmonary Embolism in Cancer Patients, Cancer patients who develop a pulmonary embolism., Diseases [C] - Cancer [C04] | | | | |
2021-001335-24: Prevention of blood clots after surgery in patients with oesophageal cancer Forebyggelse af blodpropper efter operation for kræft i spiserøret |
|
|
| Not yet recruiting | 4 | 100 | Europe | Fragmin, Injection, Fragmin | Aarhus University, Aarhus University, Aarhus University Hospital | Thromboembolism in oesophageal cancer, Blood clots forming after surgery in patients with cancer in the oesophagus., Diseases [C] - Cancer [C04] | | | | |
2019-002323-15: Pre- vs. postoperative thromboprophylaxis for liver resection – a prospective, multicenter, randomized controlled trial |
|
|
| Not yet recruiting | 4 | 1012 | Europe | Fragmin, Klexane, Solution for injection in pre-filled syringe, Fragmin, Klexane | Helsinki University Hospital, Helsinki University Hospital and Syöpäsäätiö (Finnish Cancer Foundation) | Venous thromboembolism, Venous thromboembolism, Diseases [C] - Blood and lymphatic diseases [C15] | | | | |
| Recruiting | 4 | 100 | Europe | Fragmin 5000 UNT in 0.2 ML Prefilled Syringe, Low Molecular Weight Heparin | University of Aarhus, Aarhus University Hospital | Esophageal Neoplasms, Thrombosis, Thromboembolism | 05/23 | 05/24 | | |
| Active, not recruiting | 4 | 3239 | Europe, US, RoW | theraputic heparin, unfractionated heparin, Enoxaparin, Dalteparin, Tinzaparin, Heparin, prophylactic heparin, enoxaparin, dalteparin, Fondparinux, P2Y12, Ticagrelor, Prasugrel, Clopidogrel, Crizanlizumab Injection, SGLT2 inhibitor, dapagliflozin, empagliflozin, canagliflozin, ertugliflozin | Matthew Neal MD, National Heart, Lung, and Blood Institute (NHLBI) | Covid19 | 08/23 | 06/24 | | |
NCT05255003: STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis |
|
|
| Recruiting | 4 | 50 | Canada | Enoxaparin, Lovenox, Dalteparin, Fragmin, Tinzaparin, Innohep | Ottawa Hospital Research Institute | Cancer-associated Thrombosis, Thrombocytopenia | 10/24 | 03/25 | | |
| Recruiting | 4 | 1012 | Europe | enoxaparin or tinzaparin or dalteparin, No intervention | Helsinki University Central Hospital, Academy of Finland, The Finnish Medical Association | Liver Cancer, Surgery, Thrombosis, Deep Vein, Embolism, Pulmonary, Bleeding | 02/25 | 03/25 | | |
| Recruiting | 4 | 65000 | Europe | Dalteparin Prefilled Syringe, Tinzaparin profiled syringe | Herlev Hospital | Anticoagulant, Venous Thromboembolism, Prophylaxis, Treatment | 03/25 | 03/25 | | |
| Recruiting | 4 | 6660 | Europe | Dalteparin Sodium, Tinzaparin Sodium, Enoxaparin Sodium, Rivaroxaban, Apixaban, Dabigatran Etexilate | Imperial College London | Venous Thromboembolism, Varicose Veins | 06/26 | 12/26 | | |
| Recruiting | 4 | 800 | Europe | enoxaparin/tinzaparin/dalteparin | Helsinki University Central Hospital | Pancreas Cancer, Pancreas Neoplasm, Surgery, Thrombosis, Bleeding | 08/26 | 09/26 | | |